Association of medicaid expansion of the Affordable Care Act with the stage at diagnosis and treatment of papillary thyroid cancer: A difference-in-differences analysis.

TitleAssociation of medicaid expansion of the Affordable Care Act with the stage at diagnosis and treatment of papillary thyroid cancer: A difference-in-differences analysis.
Publication TypeJournal Article
Year of Publication2021
AuthorsLimberg J, Stefanova D, Thiesmeyer JW, Ullmann TM, Bains S, Finnerty BM, Zarnegar R, Li J, Iii TJFahey, Beninato T
JournalAm J Surg
Volume222
Issue3
Pagination562-569
Date Published2021 Sep
ISSN1879-1883
KeywordsAdult, Databases, Factual, Female, Humans, Insurance Coverage, Iodine Radioisotopes, Male, Medicaid, Medical Overuse, Medically Uninsured, Middle Aged, Patient Protection and Affordable Care Act, Poverty Areas, Private Sector, Radiotherapy, Adjuvant, Thyroid Cancer, Papillary, Thyroid Neoplasms, United States
Abstract

BACKGROUND: The Affordable Care Act's (ACA) Medicaid expansion has increased insurance coverage and improved various cancer outcomes. Its impact in papillary thyroid cancer (PTC) remains unclear.

METHODS: Non-elderly patients (40-64 years-old) with PTC living in low-income areas either in a 2014 expansion, or a non-expansion state were identified from the National Cancer Database between 2010 and 2016. Insurance coverage, stage at diagnosis, and RAI administration were analyzed using a difference-in-differences analysis.

RESULTS: 10,644 patients were included. Compared with non-expansion states, the percentage of uninsured patients (adjusted-DD -2.6% [95%-CI -4.3to-0.8%],p = 0.004) and patients with private insurance decreased, and those with Medicaid coverage increased (adjusted-DD 9.7% [95%-CI 6.9-12.5%],p < 0.001) in expansion states after ACA implementation. The percentage of patients with pT1 did not differ between expansion and non-expansion states; neither did the use of RAI.

CONCLUSIONS: Medicaid expansion has resulted in a smaller uninsured population in PTC patients, but without earlier disease presentation nor change in RAI treatment.

DOI10.1016/j.amjsurg.2021.01.016
Alternate JournalAm J Surg
PubMed ID33541689